本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.37
-0.0300-0.56%
成交量:896.74萬
成交額:4,686.31萬
市值:21.85億
市盈率:-2.95
高:5.38
開:5.26
低:5.13
收:5.40
資料載入中...
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities